Table 1.
Baseline clinical patient characteristics of both groups (mean age, men, women, hypertension, diabetes mellitus, atrial fibrillation, known history of smoking, baseline NIHSS, occlusion location, IV thrombolysis). Data are presented as mean ± SD/N or % (n/N).
| Our cohort | HERMES | p | ||
|---|---|---|---|---|
| N | 70 | 634 | ||
| age (mean ± SD)/N | 68.2 ± 12.6/70 | 67.3 ± 14.7/634 | 0.6225 | |
| women (% (n/N)) | 42.8% (30/70) | 48% (304/634) | 0.4942 | |
| men (% (n/N)) | 57.2% (40/70) | 52% (330/634) | 0.1821 | |
| hypertension (% (n/N)) | 78.6% (55/70) | 56% (352/634) | 0.0003 | |
| diabetes (% (n/N)) | 18.6% (13/70) | 13% (82/634) | 0.2603 | |
| atrial fibrillation (% (n/N)) | 51.4% (36/70) | 33% (209/634) | 0.0032 | |
| smoking (% (n/N)) | 25.7% (18/70) | 31% (194/634) | 0.4788 | |
| baseline NIHSS | 17 ± 6.2/70 | 17 ± 4.5/631 | 0.5915 | |
| location | M2 | 7.1% (5/70) | 8% (51/634) | 0.9747 |
| M1 | 38.6% (27/70) | 69% (439/634) | <0.0001 | |
| ICA | 62.9% (37/70) | 21% (133/634) | <0.0001 | |
| other | 1.4% (1/70) | 2% (11/634) | 0.7653 | |
| intravenous thrombolysis (% (n/N)) | 82.9% (58/70) | 83% (526/634) | 0.885 | |